{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:28:41Z","timestamp":1791815321835,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejphar.2024.176764","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:54:31Z","timestamp":1718898871000},"page":"176764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["An 8-aminoquinoline-naphthyl copper complex causes apoptotic cell death by modulating the expression of apoptotic regulatory proteins in breast cancer cells"],"prefix":"10.1016","volume":"978","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3671-637X","authenticated-orcid":false,"given":"Nonzuzo","family":"Myeza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-7382","authenticated-orcid":false,"given":"Cathy","family":"Slabber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8979-6321","authenticated-orcid":false,"given":"Orde Q.","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-7338","authenticated-orcid":false,"given":"Sheldon","family":"Sookai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-9120","authenticated-orcid":false,"given":"Savannah C.","family":"Zacharias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-7921","authenticated-orcid":false,"given":"Carla","family":"Martins-Furness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3470-7851","authenticated-orcid":false,"given":"Leonie","family":"Harmse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ejphar.2024.176764_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112756","article-title":"Development and in vitro and in vivo evaluation of an antineoplastic copper(II) compound (Casiopeina III-ia) loaded in nonionic vesicles using quality by design","volume":"23","author":"Aguilar-Jim\u00e9nez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176764_bib2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/ejic.201600986","article-title":"Thirty years of the drug candidate NAMI\u2010A and the myths in the field of ruthenium anticancer compounds: a personal perspective","volume":"2017","author":"Alessio","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"issue":"24","key":"10.1016\/j.ejphar.2024.176764_bib3","doi-asserted-by":"crossref","first-page":"14362","DOI":"10.1039\/D1RA00172H","article-title":"Ligand substituent effect on the cytotoxicity activity of two new copper(ii) complexes bearing 8-hydroxyquinoline derivatives: validated by MTT assay and apoptosis in MCF-7 cancer cell line (human breast cancer)","volume":"11","author":"Ali","year":"2021","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176764_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1677\/joe.0.1790055","article-title":"Overexpression of wild-type p53 gene renders MCF-7 breast cancer cells more sensitive to the antiproliferative effect of progesterone","volume":"179","author":"Alkhalaf","year":"2003","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176764_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jmi.12133","article-title":"Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques","volume":"255","author":"Atale","year":"2014","journal-title":"J. Microsc."},{"key":"10.1016\/j.ejphar.2024.176764_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0162-0134(98)00010-5","article-title":"Multi-metal binding site of serum albumin","volume":"70","author":"Bal","year":"1998","journal-title":"J. Inorg. Biochem."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176764_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/0929867328666211117094550","article-title":"Copper complexes as antitumor agents: in vitro and in vivo evidence","volume":"30","author":"Balsa","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"39","key":"10.1016\/j.ejphar.2024.176764_bib8","doi-asserted-by":"crossref","first-page":"26882","DOI":"10.1074\/jbc.M114.567685","article-title":"Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses","volume":"289","author":"Biswas","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176764_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-53695-0","article-title":"Expression of the BAD pathway is a marker of triple-negative status and poor outcome","volume":"9","author":"Boac","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.176764_bib10","first-page":"1141","article-title":"Measurement of fraction unbound paclitaxel in human plasma","volume":"28","author":"Brouwer","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2024.176764_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2017.11.017","article-title":"BAD phosphorylation as a target of inhibition in oncology","volume":"415","author":"Bui","year":"2018","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.ejphar.2024.176764_bib12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1101\/pdb.prot087288","article-title":"Quantitation of apoptosis and necrosis by annexin V binding, propidium iodide uptake, and flow cytometry","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ejphar.2024.176764_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejmech.2016.10.041","article-title":"Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity","volume":"126","author":"Dam","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176764_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","article-title":"Targeting p53 for the treatment of cancer","volume":"79","author":"Duffy","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176764_bib15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ijc.27767","article-title":"Distinct tumor protein p53 mutants in breast cancer subgroups","volume":"132","author":"Dumay","year":"2013","journal-title":"Int. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176764_bib16","doi-asserted-by":"crossref","first-page":"a041332","DOI":"10.1101\/cshperspect.a041332","article-title":"Immunotherapy approaches for breast cancer patients in 2023","volume":"13","author":"Emens","year":"2023","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"29","key":"10.1016\/j.ejphar.2024.176764_bib17","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/ejic.201900644","article-title":"Monofunctional PtII complexes based on 8-aminoquinoline: synthesis and pharmacological characterization","author":"Facchetti","year":"2019","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejphar.2024.176764_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.10625.1","article-title":"Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins","volume":"6","author":"Finlay","year":"2017","journal-title":"F1000research"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176764_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1078-0432.CCR-13-0227","article-title":"Molecular pathways: targeting inhibitor of apoptosis proteins in cancer-from molecular mechanism to therapeutic application","volume":"20","author":"Fulda","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176764_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10534-018-0096-4","article-title":"Copper complex derived from S-benzyldithiocarbazate and 3-acetylcoumarin induced apoptosis in breast cancer cell","volume":"31","author":"Foo","year":"2018","journal-title":"Biometals"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176764_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"issue":"18","key":"10.1016\/j.ejphar.2024.176764_bib22","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1089\/ars.2018.7554","article-title":"Heme oxygenase-1 has an antitumor role in breast cancer","volume":"30","author":"Gandini","year":"2019","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176764_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molmed.2017.02.001","article-title":"p21: a two-faced genome guardian","volume":"23","author":"Georgakilas","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176764_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2022.115649","article-title":"Synthesis and anticancer evaluation of copper(II)- and manganese (II)-theophylline mixed ligand complexes","volume":"214","author":"Gordon","year":"2022","journal-title":"Polyhedron"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2024.176764_bib25","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.breast.2022.01.006","article-title":"Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer","volume":"62","author":"Harbeck","year":"2022","journal-title":"Breast"},{"issue":"7\u20138","key":"10.1016\/j.ejphar.2024.176764_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10495-019-01547-7","article-title":"Copper-imidazo[1,2-a]pyridines induce intrinsic apoptosis and modulate the expression of mutated p53, haem oxygenase-1 and apoptotic inhibitory proteins in HT-29 colorectal cancer cells","volume":"24","author":"Harmse","year":"2019","journal-title":"Apoptosis : Int. J. Program. Cell Death."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176764_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138607","article-title":"Aberrant apoptotic response of colorectal cancer cells to novel nucleoside analogues","volume":"10","author":"Harmse","year":"2015","journal-title":"PLoS One"},{"issue":"49","key":"10.1016\/j.ejphar.2024.176764_bib28","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1038\/onc.2017.294","article-title":"Acetylation is essential for nuclear heme oxygenase-1-enhanced tumor growth and invasiveness","volume":"36","author":"Hsu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2024.176764_bib29","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1002\/chem.201100751","article-title":"X\u2010ray and solution structures of Cu II GHK and Cu II DAHK complexes: influence on their redox properties","volume":"17","author":"Hureau","year":"2011","journal-title":"Chem. Eur J."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176764_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119160","article-title":"Copper-imidazo[1,2-a]pyridines differentially modulate pro- and anti-apoptotic protein and gene expression in HL-60 and K562 leukaemic cells to cause apoptotic cell death","volume":"1869","author":"Ismail","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2024.176764_bib31","series-title":"Molecular Oncology of Breast Cancer","first-page":"282","article-title":"The breast: comprehensive management of benign and malignant diseases","author":"Joshi","year":"2018"},{"issue":"117","key":"10.1016\/j.ejphar.2024.176764_bib32","first-page":"219","article-title":"MCF-7 breast carcinoma cells do not express caspase-3","author":"J\u00e4nicke","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.ejphar.2024.176764_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrc2728","article-title":"p53-A Jack of all trades but master of none","volume":"9","author":"Junttila","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2024.176764_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","article-title":"Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.2016","volume":"42","author":"Karimian","year":"2016","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejphar.2024.176764_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2019.121059","article-title":"A tutorial for the assessment of the stability of organometallic complexes in biological media","volume":"906","author":"Keller","year":"2020","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejphar.2024.176764_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ica.2014.12.034","article-title":"Synthesis and the characterization of Schiff-base copper complexes: reactivity with DNA, 4-NPP and BNPP","volume":"428","author":"Kozlyuk","year":"2015","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.ejphar.2024.176764_bib67","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1021\/bi00307a046","article-title":"Characterization of the copper(II) and nickel(II) transport site of human serum albumin. Studies of copper(II) and nickel(II) binding to peptide 1-24 of human serum albumin by carbon-13 and proton NMR spectroscopy","volume":"23","author":"Laussac","year":"1984","journal-title":"Biochem"},{"issue":"6","key":"10.1016\/j.ejphar.2024.176764_bib38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2174\/1871520621666210726132543","article-title":"Induction of apoptosis and autophagy by ternary copper complex towards breast cancer cells","volume":"22","author":"Lee","year":"2021","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176764_bib39","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1021\/acsmedchemlett.9b00284","article-title":"Novel copper complexes that inhibit the proteasome and trigger apoptosis in triple-negative breast cancer cells","volume":"10","author":"Li","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.ejphar.2024.176764_bib40","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"March","key":"10.1016\/j.ejphar.2024.176764_bib41","first-page":"1","article-title":"The diverse roles of heme oxygenase-1 in tumor progression","volume":"12","author":"Luu-Hoang","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176764_bib42","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7150\/thno.81847","article-title":"Role of p53 in breast cancer progression: an insight into p53 targeted therapy","volume":"13","author":"Marvalim","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2024.176764_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/bmc-2015-0030","article-title":"Extended functional repertoire for human copper chaperones","volume":"7","author":"Matson-Dzebo","year":"2016","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.ejphar.2024.176764_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ica.2017.08.043","article-title":"Copper complexes as artificial DNA metallonucleases: from Sigman's reagent to next generation anti-cancer agent","volume":"472","author":"McGivern","year":"2018","journal-title":"Inorg. Chim. Acta."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2024.176764_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays MTT-assay:.cell viability","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2024.176764_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2641","article-title":"p53 mutations in cancer","volume":"15","author":"Muller","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.176764_bib47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/1471-2407-13-516","article-title":"Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients","volume":"13","author":"Noh","year":"2013","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ejphar.2024.176764_bib48","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/cdd.2011.30","article-title":"Caspases and cancer","volume":"18","author":"Olsson","year":"2011","journal-title":"Cell Death Differ."},{"issue":"1A","key":"10.1016\/j.ejphar.2024.176764_bib49","first-page":"23","article-title":"Heme oxygenase inhibition in cancers: possible tools and targets","volume":"22","author":"Podkalicka","year":"2018","journal-title":"Contemp. Oncol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176764_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-022-06685-2","article-title":"Escalating de-escalation in breast cancer treatment","volume":"195","author":"Sacchini","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.ejphar.2024.176764_bib51","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1007\/s11033-022-07571-2","article-title":"Breast cancer in the era of precision medicine","volume":"49","author":"Sarhangi","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2024.176764_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1568026620666200628023540","article-title":"Application of a novel metallomics tool to probe the fate of metal-based anticancer drugs in blood plasma: potential, challenges and prospects","volume":"21","author":"Sarpong-Kumankomah","year":"2021","journal-title":"Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)"},{"issue":"8","key":"10.1016\/j.ejphar.2024.176764_bib53","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/cancers11081178","article-title":"p21 in cancer research","volume":"11","author":"Shamloo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2024.176764_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2024.176764_bib55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/377649a0","article-title":"Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin","volume":"377","author":"Takahara","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.176764_bib56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1186\/s12967-023-04533-5","article-title":"Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications","volume":"21","author":"Tarin","year":"2023","journal-title":"J. Transl. Med."},{"issue":"13","key":"10.1016\/j.ejphar.2024.176764_bib57","article-title":"Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT\u2013tamoxifen hybrid therapy","volume":"5","author":"Theodossiou","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejphar.2024.176764_bib58","doi-asserted-by":"crossref","first-page":"17413","DOI":"10.1039\/D1DT02783B","article-title":"Cancer molecular biology and strategies for the design of cytotoxic gold(I) and gold(III) complexes: a tutorial review","volume":"50","author":"Van der Westhuizen","year":"2021","journal-title":"Dalton Trans."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176764_bib59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.ejphar.2024.176764_bib60","doi-asserted-by":"crossref","first-page":"25535","DOI":"10.1074\/jbc.M400944200","article-title":"Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176764_bib61","article-title":"Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176764_bib62","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jmb.2017.03.030","article-title":"Mutant p53 in cancer: accumulation, gain-of-function, and therapy","volume":"429","author":"Yue","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2024.176764_bib63","series-title":"Structural, Physical and Biological Studies of Copper(II) and Rhenium(V) Schiff Base Complexes","author":"Zacharias","year":"2012"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176764_bib64","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.drudis.2021.01.015","article-title":"Biochemical pathways of copper complexes: progress over the past 5 years","volume":"26","author":"Zehra","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.ejphar.2024.176764_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfab064","article-title":"Structure elucidation, in vitro binding studies and ROS-dependent anti-cancer activity of Cu(II) and Zn(II) phthaloylglycinate(phen) complexes against MDA-MB-231 cells","volume":"13","author":"Zehra","year":"2021","journal-title":"Metallomics"},{"issue":"24","key":"10.1016\/j.ejphar.2024.176764_bib66","doi-asserted-by":"crossref","first-page":"18391","DOI":"10.1074\/jbc.C000062200","article-title":"The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21(WAF1)\/(Cip)1 promoter","volume":"275","author":"Zhang","year":"2000","journal-title":"J. Biol. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924004527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924004527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T20:11:37Z","timestamp":1721679097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924004527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":66,"alternative-id":["S0014299924004527"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176764","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An 8-aminoquinoline-naphthyl copper complex causes apoptotic cell death by modulating the expression of apoptotic regulatory proteins in breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176764"}}